RN

Rajnikant Nalawade Annasaheb

Active Director Director DIN 06711147
DIN 06711147 First appointment Dec 2013 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 6 active board seats
Past companies 3 historical roles
Total affiliations 9 Since Dec 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajnikant Nalawade Annasaheb

Data last updated:

Rajnikant Nalawade Annasaheb is a Director at Shri Shantiniketan Foundation (since 2014), Designated Partner at Wealthstone Advisors And Consultants Llp (since 2025) and Designated Partner at Kyoto Bio Pharma Llp (since 2016), and holds 3 more current directorships. The companies operate in Business Services, Pharma and Travel and Hospitality. The largest current company by reported revenue is Shri Shantiniketan Foundation at ₹4,400 (FY 2024). Earlier, Rajnikant Nalawade Annasaheb was a Director at Amazon Consultancy Private Limited (2013–2025) and Director at Kyoto Bio Pharma Private Limited (from 2013) and 1 more.

DIN 06711147
Primary Designation Director
Industry Business Services
First Appointment 10 Dec 2013
Oldest Company Age 19 yrs
Largest company Shri Shantiniketan Foundation Β· ₹4,400 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shri Shantiniketan Foundation U74999MH2012NPL238421
Director16 Dec 20142012₹4,400 (FY 2024)Active
Designated Partner27 Jun 20252025Active
Designated Partner04 Oct 20162016Active
Designated Partner25 Jan 20162016Active
Designated Partner28 May 20152015Active
Director16 Dec 20142012Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amazon Consultancy Private Limited U74140MH2008PTC178049
Director10 Dec 20132008Active
Kyoto Bio Pharma Private Limited U24233MH2010PTC207893
Director10 Dec 20132010Converted To Llp
Director10 Dec 20132007Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kyoto Bio Pharma Llp
Deccan Agro Research And Marketing Private Limited
Kyoto Bio Pharma Private Limited
Deccan Hospitality Services Private Limited
Premium access

Shareholding and investment profile for Rajnikant Nalawade Annasaheb

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajnikant Nalawade Annasaheb

Rajnikant Nalawade Annasaheb currently holds 6 directorships: Shri Shantiniketan Foundation (Director, since 16 Dec 2014, revenue β‚Ή4,400 (FY 2024)); Wealthstone Advisors And Consultants Llp (Designated Partner, since 27 Jun 2025); Kyoto Bio Pharma Llp (Designated Partner, since 04 Oct 2016); Deccan Hospitality Services Llp (Designated Partner, since 25 Jan 2016); Shiv Srushti Buildcon Llp (Designated Partner, since 28 May 2015); and 1 more.

Rajnikant Nalawade Annasaheb was first appointed on 10 Dec 2013 as Director at Amazon Consultancy Private Limited. The most recent appointment on record is 27 Jun 2025 at Wealthstone Advisors And Consultants Llp.

Rajnikant Nalawade Annasaheb held 3 earlier board appointments: Amazon Consultancy Private Limited (Director, 10 Dec 2013 to 27 Jun 2025); Kyoto Bio Pharma Private Limited (Director, from 10 Dec 2013); Deccan Hospitality Services Private Limited (Director, from 10 Dec 2013).

The current boards of Rajnikant Nalawade Annasaheb's companies include Sunita Rajesh Katkar (Shri Shantiniketan Foundation), Jyotiraditya Rajesh Katkar (Wealthstone Advisors And Consultants Llp), Yugandhara Rajesh Katkar (Wealthstone Advisors And Consultants Llp), Sunil Rajdev Singh (Shiv Srushti Buildcon Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available